Asuragen said this week that it has launched the next generation of microarray content offered through its microRNA expression profiling service.
According to the company, the “latest generation of microarrays, manufactured using GE Healthcare's CodeLink technology … [contain] 152 novel microRNAs with confirmed expression in human tissues.” The miRNAs are available only from Asuragen.